Virginia Venture Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Avant Genomicsavant-genomics.cominMay 2026 · $3M✓ verified
Avant Genomics is developing an automated platform for liquid biopsy sample preparation, using an enclosed fluidic cartridge and benchtop instruments that integrate DNA enrichment and purification for blood-based cancer detection.
BiotechHealthtechMedical DevicesCharlottesville, US
Co-investorsTitletownTech
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.